Page 348 - Markets News

Sensex, Nifty post best single-day rise in seven weeks on heavyweights

The Sensex climbed 746 points (0.9 per cent) to close at 80,604, while the Nifty added 222 points (0.9 per cent) to settle at 24,585

Bond windfall cushions NII strain for PSBs as margins shrink on rate cuts

Public sector banks saw Q1 FY26 profit rise 10.6% YoY on treasury gains and lower provisions, while NII was flat as lenders passed on policy rate cuts to customers

Indian Rupee gives up early gains to close flat; ends at 87.66/$

Indian Rupee today: The domestic currency closed flat at 87.66 against the dollar on Monday after opening 16 paise higher

Sensex gains 746 pts, Nifty nears 24,600; 3 reasons behind Monday's rally

Why Sensex, Nifty rallied on Monday: Renewed buying in PSU banks, record MF inflows and hopes of a positive outcome from the US-Russia meet helped revive the market mood in India.

Paytm, Eternal surge up to 6%, stocks near 52-week highs

Shares of Eternal, the parent company of food aggregator Zomato and quick-commerce firm Blinkit, were up 3% to ₹310.40, quoting close to its record high level of ₹314.40

Stock market close highlights: Sensex up 746pts, Nifty at 24,585; PSU Bk, Auto, Realty stocks shine

Stock market close highlights on Monday, August 11, 2025: On the BSE, Tata Motors, Eternal and Trent were the top gainers while ICICI Bank, BEL and Bharti Airtel were among the major laggards.

Last day! All Time Plastics IPO closes today; subscription rises 4x, GMP 2%

All Time Plastics IPO received bids for 42.05 million equity shares against 10.54 million shares on offer as of 2:30 PM on Monday

Sai Life Sciences shares surge 11% in 2 days on strong Q1 earnings

The rally in the share price of Sai Life Sciences comes after the company swung back to report a profit of ₹60 crore in Q1FY26

Sebi proposes single window gateway for low risk foreign investors

The new framework -- Single Window Automatic & Generalised Access for Trusted Foreign Investors (SWAGAT-FI), if implemented, would provide easier investment access to low risk foreign investors

Sun TV shares rally 8% as promoter legal notices withdrawn; check details

Sun TV shares rose 8 per cent after it said that legal notices issued by a family member to promoter Kalanithi Maran were withdrawn

JSW Cement IPO sees modest demand, fully booked on Day 3; GMP flat

JSW Cement IPO attracted bids for 221.4 million equity shares compared to 181.29 million shares on offer, resulting in overall subscription rate of only 1.22 times.

Nykaa Q1 results preview: Check estimates, date & other key details

FSN E-Commerce Ventures, parent of Nykaa, will release its Q1 results this week; here's how the beauty and cosmetic company is poised to fare in Q1

Yatharth hits new high, zooms 52% in 3 months; what's driving the rally?

Yatharth Hospitals said the company is set to be included as a constituent of the MSCI India Small Cap Index, effective from the upcoming index rebalancing date of August 26, 2025.

BEML shares rally 5% on securing maiden overseas contract; key details here

BEML share price rallied today after the company announced that it has secured its maiden overseas contract in the Rail and Metro segment from Malaysia.

Puravankara slips 5% after posting ₹68 crore Q1 loss; check details here

Puravankara shares logged their steepest intraday fall since June after reporting a loss of ₹68 crore in Q1FY26

SBI, HPCL, BSE, LIC, Godrej Consumer:How to trade these news-driven stocks?

Technical charts show that SBI and Godrej Consumer shares could possibly rally up to 19% from here; while HPCL, BSE and LIC face up to 11% downside risk.

Biocon shares slip 3% as Q1 results miss estimates; should you sell?

Biocon shares fell 3 per cent after it reported a 95.2 per cent decline in net profit in Q1FY26

Indigo Paints share slips 8%, nears 52-week low on disappointing Q1 results

Revenue impacted due to early monsoon which affected the roads and metro projects.

Info Edge Q1 results: Why analysts have a split verdict on this stock?

Info Edge's standalone revenue stood at ₹7,364 crore, up 15.3 per cent year-on-year (Y-o-Y), with billings rising 11.2 per cent to ₹6,442 crore.

Zydus Lifesciences up 2% after USFDA nods Diltiazem Hydrochloride tablets

Zydus Lifesciences share price rose 2 per cent, logging an intra-day high at ₹955 per share on BSE after USFDA gave its approval for Diltiazem Hydrochloride Tablets.